Oncoceutics

    OverviewSuggest Edit

    Oncoceutics is a drug discovery and development company focused on selective G protein-coupled receptor antagonists for oncology. It offers ONC201, an orally active DRD2 small molecule antagonist that can be used against advanced cancers.
    TypePrivate
    Founded2009
    HQPhiladelphia, PA, US
    Websiteoncoceutics.com

    Latest Updates

    Employees (est.) (Sept 2021)7
    Cybersecurity ratingBMore

    Key People/Management at Oncoceutics

    Lee Schalop

    Lee Schalop

    Chief Executive Officer and Director
    Martin Stogniew

    Martin Stogniew

    Chief Development Officer and Director
    Sebastian Franzinger

    Sebastian Franzinger

    Vice President, Finance and Business Development
    Joshua Allen

    Joshua Allen

    Chief Scientific Officer
    Varun Prabhu

    Varun Prabhu

    Vice President, Research and Development
    Raymond Wong

    Raymond Wong

    Chairman
    Show more

    Oncoceutics Office Locations

    Oncoceutics has offices in Philadelphia and New York
    Philadelphia, PA, US (HQ)
    3675 Market St #200
    New York, NY, US
    1460 Broadway
    Show all (2)

    Oncoceutics Financials and Metrics

    Summary Metrics

    Founding Date

    2009

    Oncoceutics Cybersecurity Score

    Cybersecurity ratingPremium dataset

    B

    81/100

    SecurityScorecard logo

    Oncoceutics Online and Social Media Presence

    Embed Graph

    Oncoceutics News and Updates

    Chimerix Acquires Oncoceutics to Expand Pipeline with Late-Stage Oncology Program

    ONC201 Registrational Trial for Recurrent H3 K27M-mutant Glioma

    Oncoceutics Commemorates GBM Awareness Day

    Philadelphia, PA (July 22, 2020) – Oncoceutics, a clinical-stage drug discovery and development company, commemorates GBM Awareness Day this July and expresses its support for all those affected by this devastating form of brain cancer. Glioblastoma (GBM) is the most common type of malignant brain t…

    Oncoceutics Frequently Asked Questions

    • When was Oncoceutics founded?

      Oncoceutics was founded in 2009.

    • Who are Oncoceutics key executives?

      Oncoceutics's key executives are Lee Schalop, Martin Stogniew and Sebastian Franzinger.

    • How many employees does Oncoceutics have?

      Oncoceutics has 7 employees.

    • Who are Oncoceutics competitors?

      Competitors of Oncoceutics include Jiangsu Hansoh Pharmaceutical Group, 3sbio and Takeda Oncology.

    • Where is Oncoceutics headquarters?

      Oncoceutics headquarters is located at 3675 Market St #200, Philadelphia.

    • Where are Oncoceutics offices?

      Oncoceutics has offices in Philadelphia and New York.

    • How many offices does Oncoceutics have?

      Oncoceutics has 2 offices.